In Vitro Cytotoxicity of Cyclodextrin-bonded Birch Bark Extract

Abstract

Triterpenoids from birch bark, like betulin, seem to have an anticancer potential which needs to be further investigated. Aim of this study was first to explore whether a cyclodextrin-solubilised triterpenoid extract (STE) from birch bark induces selective cytotoxic effects in primary liver cancer cells compared to healthy human hepatocytes. Second, selective cytotoxicity against several tumour cell lines should be analysed. For this purpose, human liver cancer cells derived from mouse xenografts (LIXF 575), healthy human hepatocytes, and 42 different human tumour cell lines were incubated with different concentrations of STE corresponding to 4.3 µM – 137.5 µM betulin (BE). Cytotoxicity was tested with the WST-1 cell proliferation assay, apoptosis with caspase 3/7-activity, and necrosis was determined by the propidiumiodid uptake assay. The pathway of cytotoxic effects was further investigated by immunoblotting of apoptosis inducing factor (AIF) and p53. The monolayer assay was used to analyse selectivity of STE towards different tumour cell lines. STE significantly (p < 0.001) reduced viability and induced apoptosis of LIXF cells in low concentrations corresponding to 8.6 µM BE, while human hepatocytes were affected only in concentrations ≥ 68.8 µM. Cell death occurred in a p53 independent manner, and AIF was not involved. The mean IC₅₀ in the 42 tumour cell lines corresponded to 4.3 µM BE and ranged from 2.05 µM to 8.95 µM BE content. Selectivity was, therefore, rather low. In conclusion, STE exhibits in low concentrations cytotoxicity in a broad spectrum of primary cancer cells and cancer cell lines, which is, at least in LIXF cells, induced by caspase 3/7 mediated apoptosis. STE is far less toxic in hepatocytes. The anticancer potential of STE should be further characterised and also investigated in animal models.

Key words

Betulaceae - Betula alba - betulin - triterpenoids - cyclodextrin - hepatocytes - anthroposophical medicine

• References

• 1 Laszczyk M. Pentacyclic triterpenoids of lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 2009; 75: 1549-1560
• 2 Ekmann R. The submarin monomers and triterpenoids of the outer bark of Betula verrucosa EHRH. Holzforschung 1983; 37: 205-211
• 3 Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME, Debatin KM. Betulinic acid triggers CD95 (APO-1/Fas)- and p 53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997; 57: 4956-4964
• 4 Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S. Oleanolic acid induces apoptosis in human leukemia cells through caspase activation and poly(ADP-ribose) polymerase cleavage. Acta Biochim Biophys Sin 2007; 39: 803-809
• 5 Martín R, Ibeas E, Carvalho-Tavares J, Hernández M, Ruiz-Gutierrez V, Nieto M. Natural triterpenic diols promote apoptosis in astrocytoma cells through ROS-mediated mitochondrial depolarization and JNK activation. PLos ONE 2009; 4: e5975
• 6 Li Y, He K, Huang Y, Zheng D, Gao C, Cui L, Jin Y. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Mol Carcinogen 2010; 49: 630-640
• 7 Prasad S, Madan E, Nigam N, Roy P, George J, Shukla Y. Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkB signaling pathways. Cancer Biol Ther 2009; 8: 1632-1639
• 8 Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub R, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SL. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011; 475: 231-234
• 9 Yap TA, Sandhu SK, Carden CP, de Bono JS. Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic. CA Cancer J Clin 2011; 61: 31-49
• 10 Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995; 49: 57-68
• 11 Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TK, Pezzuto JM. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995; 1: 1046-1051
• 12 Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C, Formelli F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 2002; 175: 17-25
• 13 Jäger S, Laszczyk M, Scheffler A. A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 2008; 13: 3224-3235
• 14 Del Valle M. Cyclodextrins and their uses: a review. Process Biochemistry 2004; 39: 1033-1046
• 15 Özkan Y, Atay T, Dikmen N, Isimer A, Aboul-Enein HY. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with b-cyclodextrin. Pharm Acta Helv 2000; 74: 365-370
• 16 Redenti E, Szente L, Szejtli J. Cyclodextrin complexes of salts of acidic drugs: thermodynamic properties, structural features and pharmaceutical applications. J Pharm Sci 2001; 90: 979
• 17 Tommasini S, Raneri D, Ficarra R, Calabrò ML, Stancanelli R, Ficarra P. Improvement in solubility and dissolution rate of flavonoids by complexation with β-cyclodextrin. J Pharm Biomed Anal 2004; 35: 379-387
• 18 Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev 1999; 36: 125-141
• 19 Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs 1995; 6: 522-532
• 20 Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 2001; 98: 8012-8017
• 21 Roth T, Burger AM, Dengler W, Willmann H, Fiebig HH. Human tumor cell lines demonstrating the characteristics of patient tumors as useful models for anticancer drug screening. In: Fiebig HH, Burger AM, editors Relevance of tumor models for anticancer drug development. chapter 54 Basle: Karger; 1999: 145-156
• 22 Fiebig HH, Dengler WA, Roth T. Human tumor xenografts: predictivity, characterization, and discovery of new anticancer agents. In: Fiebig HH, Burger AM, editors Relevance of tumor models for anticancer drug development. chapter 54 Basle: Karger; 1999: 29-50
• 23 Fiebig HH, Berger DP, Dengler WA, Wallbrecher E, Winterhalter BR. Combined in vitro/in vivo test procedure with human tumor xenografts. In: Fiebig HH, Berger DP, editors Immunodeficient mice in oncology. Chapter 42 Basle: Karger; 1992: 321-351
• 24 Laszczyk M, Jäger S, Simon-Haarhaus B, Scheffler A, Schempp CM. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (Betulae Cortex). Planta Med 2006; 72: 1389-1395
• 25 Strüh CM, Jäger S, Schempp CM, Scheffler A, Martin SF. A novel triterpene extract from mistletoe induces rapid apoptosis in murine B16.F10 melanoma cells. Phytother Res Epub ahead of print 08.02.2012; DOI: 10.1002/ptr.4604.
• 26 Shimpi S, Bahskar C, Shimpi P. Cyclodextrins: Application in different routes of drug administration. Acta Pharm 2005; 55: 139-156
• 27 Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med 2007; 73: 157-162
• 28 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 29 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 30 Beckers T, Kelter G, Schüler J, Hofmann M, Fiebig HH, Pomeroy J, Uhlig MT, Donoho GP, Yingling YM. In vitro profiling of new targeted anticancer agents using a 30 cell line panel established from the Oncotest patient-derived tumor xenograft collection. Denver (CO), Philadelphia (PA): Proceedings of the 100th annual AACR Meeting 2009: 4699
• 31 Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Landi L, Prata C, Berridge MV, Grasso C, Fiebig HH, Kelter G, Burger AM, Kunkel MW. Antitumor activity of bis-indole derivatives. J Med Chem 2008; 51: 4563-4570
• 32 Akematsu T, Endoh H. Role of apoptosis-inducing factor (AIF) in programmed nuclear death during conjugation in Tetrahymena thermophila . BMC Cell Biol 2010; 1: 1-15
• 33 Poon IKH, Hulett MD, Prish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17: 381-397
• 34 Szuster-Ciesielska A, Plewka K, Daniluk J, Kandefer-Szerszen M. Betulin and betulinic acid attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production and by influencing intracellular signalling. Toxicology 2011; 280: 152-163
• 35 Marcellus RC, Teodoro JG, Charbonneau R, Shore GC, Branton PE. Expression of p 53 in saos-2 osteosarcoma cells induces apoptosis which can be inhibited by BcI-2 or the adenovirus EIB-55 kDa protein. Cell Growth Differ 1996; 7: 1643-1650
• 36 Mai HD, Minh HNT, Pham VC, Bui KN, Nguyen VH, Chau VM. Lignans and other constituents from the roots of the Vietnamese medicinal plant Pseuderanthemum palatiferum . Planta Med 2011; 77: 951-954
• 37 Drag M, Surowiak P, Drag-Zalesinska M, Dietel M, Lage H, Oleksyszyn J. Comparison of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules 2009; 14: 1639-1651
• 38 Pyo JS, Roh SH, Kim DK, Lee JG, Lee YY, Hong SS, Kwon SW, Park JH. Anti-cancer effect of betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. Planta Med 2009; 75: 127-131
• 39 Delebinski CI, Jaeger S, Kemnitz-Hassanin K, Henze G, Lode HN, Seifert GJ. A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia. Cell Prolif 2012; 45: 176-187
• 40 Huyke C, Reuter J, Rödig M, Kersten A, Laszczyk M, Scheffler A, Nashan D, Schempp C. Treatment of actinic keratoses with a nove betulin-based oleogel. A prospective, randomized, comparative pilot study. JDDG 2009; 7: 128-133